{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:46:22Z","timestamp":1791913582216,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpsychires.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:20:38Z","timestamp":1788823238000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-4977","authenticated-orcid":false,"given":"Maurizio","family":"Pompili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sarubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"De Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fascetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Anna","family":"Trocchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Erbuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-871X","authenticated-orcid":false,"given":"Isabella","family":"Berardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.09.005_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s43045-023-00369-3","article-title":"Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries","volume":"30","author":"Ahmed","year":"2023","journal-title":"Middle East Curr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2026.112846","article-title":"Population-based prevalence and pharmacotherapy sequences of treatment-resistant depression in Germany","volume":"110","author":"Bayas","year":"2026","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1986.tb27888.x","article-title":"Hopelessness as a predictor of eventual suicide","volume":"487","author":"Beck","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/ajp.147.2.190","article-title":"Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients","volume":"147","author":"Beck","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1943-278X.1999.tb00758.x","article-title":"Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients","volume":"29","author":"Beck","year":"1999","journal-title":"Suicide Life-Threatening Behav."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib7","series-title":"BDI-II: Beck Depression Inventory Manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1176\/ajp.142.5.559","article-title":"Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation","volume":"142","author":"Beck","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1037\/h0037562","article-title":"The measurement of pessimism: the Hopelessness Scale","volume":"42","author":"Beck","year":"1974","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/a-2154-0828","article-title":"Interpersonal needs, mental pain, and hopelessness in psychiatric inpatients with suicidal ideation","volume":"56","author":"Berardelli","year":"2023","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JCP.0000000000001465","article-title":"Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior","volume":"41","author":"Canuso","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1943-278X.1998.tb00639.x","article-title":"Inadequate response to therapy as a predictor of suicide","volume":"28","author":"Dahlsgaard","year":"1998","journal-title":"Suicide Life-Threatening Behav."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2026.106804","article-title":"From psychache to neuroplasticity: a unified rescue-repair model of ketamine's anti-suicidal action","volume":"188","author":"Domany","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib19","first-page":"321","article-title":"Quality of Life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib20","article-title":"Spravato: EPAR product information","year":"2025","journal-title":"European Medicines Agency"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jad.2022.12.028","article-title":"Therapeutic alliance and change in suicide ideation among psychiatric inpatients at risk for suicide","volume":"323","author":"Fartacek","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib23","series-title":"Spravato (Esketamine) Nasal Spray: Highlights of Prescribing Information","year":"2019"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib24","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2010.04.032","article-title":"Explained factors of suicide attempts in major depression","volume":"127","author":"Hantouche","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/bcp.12845","article-title":"New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs","volume":"82","author":"Ign\u00e1cio","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10673229.2011.614099","article-title":"Quality of life: the ultimate outcome measure of interventions in major depressive disorder","volume":"19","author":"IsHak","year":"2011","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/jcm15010250","article-title":"Effectiveness of intranasal esketamine on suicidal ideation and depressive symptoms in patients with treatment-resistant depression: a longitudinal study","volume":"15","author":"Leonardi","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib31","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X392347250929114024","article-title":"Gender differences in suicidal and self-harming responses to esketamine: a real-world retrospective study","volume":"23","author":"Martiadis","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2003.07.004","article-title":"Quality of life assessments in major depressive disorder: a review of the literature","volume":"26","author":"Papakostas","year":"2004","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib38","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12889","article-title":"Efficacy of esketamine augmentation in major depressive disorder: a meta-analysis","volume":"81","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12991-019-0232-8","article-title":"Critical appraisal of major depression with suicidal ideation","volume":"18","author":"Pompili","year":"2019","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12991-024-00490-5","article-title":"On mental pain and suicide risk in modern psychiatry","volume":"23","author":"Pompili","year":"2024","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152430","article-title":"Routine treatment pathways in a cohort of patients with major depression and suicidality in Italy: the ARIANNA observational study","volume":"127","author":"Pompili","year":"2023","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib42","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1192\/j.eurpsy.2022.2312","article-title":"High depression symptomatology and mental pain characterize suicidal psychiatric patients","volume":"65","author":"Pompili","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jad.2013.03.026","article-title":"Affective temperaments and hopelessness as predictors of health and social functioning in mood disorder patients: a prospective follow-up study","volume":"150","author":"Pompili","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/hup.70008","article-title":"Efficacy of intranasal esketamine in treatment-resistant depression: a six-month real-world follow-up study of depressive symptoms, hopelessness, and suicide risk","volume":"40","author":"Pompili","year":"2025","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2013suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2026.104983","article-title":"Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: a real-world longitudinal study of suicidal ideation and self-harm","volume":"120","author":"Raffone","year":"2026","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib48","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa2304145","article-title":"Esketamine nasal spray versus quetiapine for treatment-resistant depression","volume":"389","author":"Reif","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib50","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2147\/NDT.S486118","article-title":"Esketamine nasal spray: rapid relief for TRD and suicide Prevention\u2014mechanisms and pharmacodynamics","volume":"20","author":"Song","year":"2024","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib51","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib53","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11126-020-09871-x","article-title":"Adverse effects of esketamine for the treatment of major depressive disorder: findings from randomized controlled trials","volume":"93","author":"Yang","year":"2022","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.jpsychires.2026.09.005_bib55","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41386-023-01577-5","article-title":"Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study","volume":"48","author":"Zaki","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.09.005_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient's perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am. J. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626004401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:40Z","timestamp":1791910600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626004401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0022395626004401"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.09.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}